Junkang Zhao

Dr. Junkang Zhao


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2024 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
YZYajie Zhao
Yajie Zhao
QGQian Gao
Qian Gao
JZJunyan Zhang
Junyan Zhang
JWJuping Wang
Juping Wang
TATetsuya Araki
Tetsuya Araki
JZJunkang Zhao
Junkang Zhao
Plant-based diets have been found to be associated with hypertension. Dietary intake is a dynamic and changing process that can be better characterized by trajectories of dietary indices. However, the associations between plant-based diet trajectories and hypertension over time remained unknown. We used data from the China Health and Nutrition Survey 2004–2015 to analyze a cohort of Chinese adults ≥ 18 years of age who had no hypertension at baseline. Plant-based diets were measured by an overall plant-based diet index (PDI), healthful plant-based diet index (hPDI), and unhealthful plant-based diet index (uPDI) based on three 24-hour recalls. Trajectories of PDI, hPDI, and uPDI (2004 to 2011) were identified using group-based trajectory modeling. The associations between trajectories of PDIs and the risk of new-onset hypertension were estimated using Cox proportional hazard models. We identified three trajectories for PDI, two for hPDI, and four for uPDI among the 2853 participants with a mean follow-up of 9.6 years. Compared with the PDI “low and stable” class, the PDI “high and decreasing” class had a 23% decreased risk (HR: 0.77; 95% CI: 0.62–0.95) of hypertension. There was no significant association with PDI “low and increasing” class. Compared with the hPDI “low and stable” class, the hPDI “high and stable” class had a 24% decreased risk (HR: 0.76; 95%CI: 0.64–0.91). For uPDI trajectories, compared with the “low and decreasing” class, the “high and increasing,” “high and stable,” and “low and increasing” classes had increased risks of 43% (HR: 1.43; 95% CI: 1.06–1.94), 77% (HR: 1.77; 95% CI: 1.26–2.49), and 72% (HR: 1.72; 95% CI: 1.26–2.33), respectively. This study underscores the importance of maintaining high intakes of healthful plant-based diets and low intakes of unhealthful plant-based diets overtime for hypertension prevention.

16 January 2026 in Mediators of Inflammation
Verified
Journal Article
Open access
YXYangyu Xu
Yangyu Xu
HZHong Zhao
Hong Zhao
YGYuxiang Gao
Yuxiang Gao
LZLi Zhao
Li Zhao
JHJiannan Han
Jiannan Han
LZLiyun Zhang
Liyun Zhang
Background: The accelerating process of global aging has made the burden of age‐related diseases increasingly severe, and traditional chronological age fails to reflect individual heterogeneity in aging. The neutrophil percentage‐to‐albumin ratio (NPAR), is a multidimensional health assessment index composed of inflammatory markers (neutrophils) and nutritional markers (albumin) to reflect inflammation and nutritional status, has shown unique potential in rheumatoid arthritis (RA) research. However, its association with biological age (BA; such as Klemera–Doubal method [KDM] age and phenotypic age, PhenoAge) has not yet been systematically validated in RA patients. By evaluating NPAR indicators in patients with RA, this study intends to reveal its value as a potential biomarker for predicting biological aging and its acceleration. Methods: This study was based on the National Health and Nutrition Survey 1999–2018 cycle database, and a cross‐sectional analysis of 1053 adult patients with RA was included. Core variable definitions include: neutrophil–albumin ratio (NPAR) = percentage of neutrophils (%)/albumin (g/dL); BA was calculated by the KDM (including 10 biomarkers) and the PhenoAge algorithm, respectively. Accelerated aging is quantified as the difference between BA and chronological age. The statistical analysis used a multi‐model validation strategy: 1) multivariate linear regression to evaluate the association between NPAR and continuous aging acceleration indicators; 2) the restricted cubic spline (RCS) model explores the nonlinear relationship; 3) stratified subgroup analysis to test for effect heterogeneity. All models were stratified for sociodemographic characteristics (age, sex, and ethnicity), lifestyle factors (smoking, alcohol consumption, and physical activity), and clinical covariates (body mass index [BMI], hypertension, and history of diabetes). Results: In an analysis of 1053 RA patients in the United States, women accounted for 56.48% and men for 43.52%; the group with the highest NPAR (T3) showed more significant aging characteristics (≥65 years old 34.75%, females 62.80%, and diabetes 27.69%) and higher biological aging acceleration rates (KDM acceleration 42.81% vs. low group 25.81%; PhenoAge acceleration 62.13% vs. 37.74%; all p < 0.001). After adjustment for multiple factors, the BA of KDM increased by 0.86 years for every 1 unit increase in NPAR (95% confidence interval [CI]: 0.39–1.32, p < 0.001), and PhenoAge increased by 1.32 years (95% CI: 0.93–1.71, p < 0.001). Taking the lowest NPAR group (T1) as the reference group, the highest NPAR group (T3) had an increased risk of accelerated aging of KDM by 149% (OR = 2.49, 95% CI: 1.44–4.31), and the risk of PhenoAge increased sharply by 259% (OR = 3.59, 95% CI: 2.17–5.95). Nonrestrictive spline curve analysis further revealed that there was a nonlinear positive correlation between the NPAR index and biological aging. When NPAR > 13.128, the growth rate of biological aging was significantly accelerated ( p for nonlinear = 0.05), while when NPAR > 14.512, the risk of phenotypic aging accelerated sharply ( p for nonlinear = 0.002). Area under the curve (AUC) of NPAR in the combined model for predicting biological senescence acceleration was 0.71–0.75. Discussion: Elevated NPAR is significantly associated with accelerated biological aging in RA patients, and the mechanism may involve neutrophil migration dysfunction, oxidative damage caused by albumin deficiency, and chronic inflammatory pathways (such as NF‐ κ B activation). As a low‐cost inflammatory marker, NPAR holds promise for integration into clinical aging risk assessment systems to identify high‐risk RA populations requiring early intervention. The study’s limitations include the inability to infer causality due to the cross‐sectional design and a relatively small sample size, necessitating further validation through cohort studies in the future.

30 January 2026 in Medicine
Verified
Journal Article
Open access
QNQingmei Niu
Qingmei Niu
JZJunkang Zhao
Junkang Zhao
YJYatian Jia
Yatian Jia
SDShuo Ding
Shuo Ding
YGYuxiang Gao
Yuxiang Gao
QZQian Zhang
Qian Zhang
This study examines the association between the aggregate index of systemic inflammation (AISI) and mortality among individuals with abdominal obesity, aiming to provide a scientific basis for accurate identification of high-risk individuals and the implementation of early interventions. This study utilized data from the National Health and Nutrition Examination Survey (NHANES) 1999–2016 to include adults with abdominal obesity. The AISI was calculated as (neutrophil count × platelet count × monocyte count)/lymphocyte count. Participants were linked to the National Death Index to determine vital status, with mortality follow-up extending through December 31, 2019. The association between the AISI and mortality risk in individuals with abdominal obesity was examined through Kaplan–Meier survival analysis, weighted Cox proportional hazards regression, subgroup stratification, and restricted cubic spline modeling. This cohort study enrolled 15,839 adult participants with abdominal obesity. During a median follow-up of 119 months, 2223 deaths were recorded. Kaplan–Meier survival analysis showed that elevated levels of the AISI were significantly associated with reduced survival probability. After comprehensive adjustment for multiple potential confounders, multivariate Cox proportional hazards regression revealed a significant positive association between AISI levels and all-cause mortality risk in individuals with abdominal obesity. When AISI was treated as a continuous variable, each 1-unit increase was associated with a 1% higher risk of death (fully adjusted HR = 1.01, 95% CI: 1.01–1.01, P < .001). When dichotomized at the median, the high AISI group exhibited a 16% increased risk of mortality compared to the low AISI group (fully adjusted HR = 1.16, 95% CI: 1.04–1.30, P = .010). Restricted cubic spline analysis confirmed a statistically significant linear relationship ( P for overall < .001; P for nonlinearity = .192). Subgroup analyses indicated heterogeneity in this association across marital status subgroups (interaction P = .017). This study demonstrates that elevated AISI levels are associated with increased mortality risk among individuals with abdominal obesity. These findings underscore the value of AISI as a prognostic indicator for mortality in this at-risk population. The integration of AISI into clinical inflammatory assessment frameworks may facilitate the establishment of dynamic surveillance strategies for identifying and monitoring high-risk individuals.

1 January 2025 in Mediators of Inflammation
Verified
Journal Article
Open access
JZJunkang Zhao
Junkang Zhao
JHJiannan Han
Jiannan Han
XFXiuying Fan
Xiuying Fan
JKJie Kang
Jie Kang
RWRuonan Wu
Ruonan Wu
LZLiyun Zhang
Liyun Zhang
Purpose: Evidence is accumulating that links gut microbiota, a crucial component of the immune environment, to Sjogren’s syndrome (SS). The mechanisms underlying the influence of gut microbiota on the onset and development of SS are still not completely understood. To this end, we applied a Mendelian randomization (MR) framework to investigate whether inflammatory cytokines mediate the association of gut microbiota with SS. Methods: Our MR analysis leveraged publicly available GWAS data, including information on 211 gut microbiota taxa sourced from the MiBioGen consortium (18,340 participants), summary statistics for 91 inflammatory cytokines obtained from a study of 14,824 individuals, and genetic data for SS derived from the UK Biobank (407,746 participants). To investigate causal associations between gut microbiota and SS, we primarily employed the inverse variance weighted method, supported by additional techniques such as MR‐Egger, simple mode, weighted median, and weighted mode for validation. The potential mediating effect of inflammatory cytokines in the gut microbiota–SS relationship was investigated using both mediation MR and multivariable MR (MVMR) analyses. Results: MR analysis identified five microbiota taxa causally associated with SS. Particularly, class Gammaproteobacteria (OR = 3.468, 95% CI = 1.139–10.557, p = 0.029) and genus Peptococcus (OR = 1.722, 95% CI = 1.082–2.471, p = 0.022) were significantly associated with an increased risk of developing SS. Six inflammatory cytokines were identified as potentially causal, with Axin‐1 (OR = 2.556, 95% CI = 1.072–6.096, p = 0.034) and C‐X‐C motif chemokine 10 levels (CXCL10) (OR = 3.049, 95% CI = 1.428–6.513, p = 0.004) being the most critical contributors. Mediation MR analysis showed that Axin‐1 levels mediated 16.96% of the causal effect of class Gammaproteobacteria on SS, CXCL10 levels mediated 36.78% of the causal effect of genus Coprococcus3 on SS. Conclusion: The findings suggest that certain gut microbiota is sociated with an increased risk of SS, mediated by specific inflammatory cytokines.

16 October 2026 in Medicine
Verified
Journal Article
Open access
YXYangyu Xu
Yangyu Xu
HZHong Zhao
Hong Zhao
YGYuxiang Gao
Yuxiang Gao
JHJiannan Han
Jiannan Han
ZWZewen Wu
Zewen Wu
JZJunkang Zhao
Junkang Zhao
Cardiovascular disease (CVD) is a major cause of excess mortality among patients with rheumatoid arthritis (RA). Conventional risk assessment may not fully capture the metabolic abnormalities and physiological vulnerability associated with RA. We investigated whether the triglyceride-glucose–frailty index (TyG-FI), which combines a surrogate marker of insulin resistance with accumulated health deficits, was associated with prevalent CVD and cardiovascular mortality among adults with RA. We analyzed 1090 adults with self-reported RA from 10 cycles of the National Health and Nutrition Examination Survey conducted between 1999 and 2018. TyG-FI was calculated as the product of the triglyceride-glucose index and a 49-item deficit-accumulation frailty index. Multivariable logistic regression was used to examine the association with prevalent CVD, whereas Cox proportional hazards regression was used to examine cardiovascular mortality. Restricted cubic splines, subgroup analyses, sensitivity analyses, and discrimination analyses were conducted as secondary analyses. In the fully adjusted models, each 1-unit higher TyG-FI was associated with higher odds of prevalent CVD (odds ratio, 4.50; 95% confidence interval, 3.20–6.33) and a higher hazard of cardiovascular mortality (hazard ratio, 1.77; 95% confidence interval, 1.16–2.70). The reported areas under the receiver operating characteristic curve were 0.80 for prevalent CVD and 0.81 for cardiovascular mortality in models incorporating TyG-FI, compared with 0.73 and 0.80, respectively, in models incorporating TyG. An exploratory subgroup analysis suggested a stronger association between TyG-FI and prevalent CVD among participants aged ≤65 years ( P for interaction = .044). Higher TyG-FI was associated with prevalent CVD and cardiovascular mortality among US adults with self-reported RA. TyG-FI may capture complementary metabolic and frailty-related information; however, its incremental predictive value, calibration, clinical utility, and external validity require further evaluation before clinical implementation.

18 September 2026 in Medicine
Verified
Journal Article
Open access
CHChunrong He
Chunrong He
JZJunkang Zhao
Junkang Zhao
This study aims to systematically assess the research productivity of artificial intelligence (AI) technologies and depression using bibliometric methods, while also exploring the trends and prospects of AI applications in the diagnosis, prediction, and treatment of depression. This study employs bibliometric analysis, using the Web of Science database to collect relevant literature on depression and AI from 2000 to 2024. By analyzing indicators such as changes in the number of publications, keyword co-occurrence, author collaboration networks, and academic impact evaluation, the study comprehensively assesses the research dynamics and key topics in this field. The literature data are analyzed using visualization tools to identify core research themes and future development trends. From 2000 to 2024, the number of studies combining depression and AI showed steady growth. This study identified a total of 1437 papers published in 766 academic journals. Keyword analysis revealed that machine learning, deep learning, natural language processing, chatbots, and neuromorphic computing are the primary technological approaches used in this research. Regarding application domains, publications were categorized into screening (173 articles), diagnosis (279 articles), and treatment (944 articles), with a smaller group covering other aspects (41 articles). Additionally, international collaborative research has increased year by year, with particularly prominent scientific activities observed in the United States, China, and the United Kingdom. AI technology has demonstrated significant potential in the research and application of depression, particularly in precise diagnosis, personalized treatment, and early intervention. Nevertheless, key research gaps persist; long-term efficacy evidence is scarce, lack of standardized validation, and cross-disciplinary integration remains insufficient. This study employs bibliometrics analysis to map the field’s evolution, identifying these critical areas requiring focused research and collaboration to fully harness AI’s potential against depression.